Article
A genome-wide association study using HapMap cell lines reveals modulators of cellular response to cyclophosphamide.
Future oncology (London, England) - 1 Jun 2025
Gbadamosi Mohammed O, Bhise Neha, Ghosh Taraswi Mitra, Molchan Elizabeth K, Streeks Kathleen, Puglise Jason, Ohaegbulam Alyssa, Makarem Mariana, Olabige Oluwaseyi, Yang Changlin, Ricks-Santi Luisel, Mitchell Duane A, Fridley Brooke L, Lamba Jatinder K
Abstract excerpt
AIMS: This study identifies single-nucleotide polymorphisms (SNPs) associated with cellular response to cyclophosphamide (CTX) using phosphoramide mustard (PM), its primary cytotoxic metabolite, and explores the downstream consequences for breast cancer (BC) patients. METHODS: We analyzed 1,978,545 SNPs from EBV-transformed lymphoblastic cell lines (LCLs) derived from 53 unrelated European individuals, in a...
Topics
Join the communities discussing this publication.
